Eleven Biotherapeutics (EBIO) Given a $2.00 Price Target by HC Wainwright Analysts

Big Money Sentiment increased to 2.25 in Q4 2017. It has change of 1.70, from 2017Q3's 0.55. It is positive, as 2 investors sold Eleven Biotherapeutics, Inc. shares while 2 reduced holdings.

An institutional investor recently raised its position in Eleven Biotherapeutics stock. Funds hold 1.80 million shares thus 48.09% more from 2017Q3's 1.21 million shares. Morgan Stanley, a New York-based fund reported 12,062 shares. (NASDAQ:EBIO). Fiduciary Tru Comm owns 20,000 shs or 0% of their U.S. capital. Northern Tru Corporation holds 0% in Eleven Biotherapeutics, Inc. (NASDAQ:EBIO). Blackrock reported 445,463 shares or 0% of all its holdings. 600 were accumulated by Citigroup. Panagora Asset Mngmt invested in 0% or 3,475 shs. Citadel Advsr Limited Liability Co, a Illinois-based fund reported 15,372 shs. Two Sigma Ltd invested 0% of its portfolio in Eleven Biotherapeutics, Inc. (NASDAQ:EBIO). Geode Cap Management Ltd Liability Corp holds 56,222 shs. Royal Bancorp Of Canada invested in 0% or 505 shs. Parallax Volatility Advisers Limited Partnership has 36,761 shs.

HC Wainwright set a $2.00 price target on Eleven Biotherapeutics (NASDAQ:EBIO) in a report published on Wednesday, April 18th. On Apr, 28 it was announced by Barchart.com. The company has market cap of $108.20 million. The brokerage now has a "buy" rating on the biopharmaceutical company's stock.

Eleven Biotherapeutics stock opened at $2.51 on Thursday. (NASDAQ:EBIO)'s earnings report, according to Zacks. The company traded as low as $2.60 and last traded at $2.41, with a volume of 5325143 shares changing hands. They expect $-0.13 EPS, up 48.00 % or $0.12 from last year's $-0.25 per share.

Eleven Biotherapeutics, Inc, a biologic oncology company, focuses on the design and development of targeted protein therapeutics (TPTs). It develops products based on its proprietary TPT platform and focused on addressing areas of unmet medical needs in cancer. The company's lead product candidates include Vicinium that is in Phase 3 clinical trial in the United States and Canada for the treatment of non-muscle invasive bladder cancer; and Proxinium for use in treating squamous cell carcinoma of the head and neck.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Notícias recomendadas

  • BlackRock (NYSE:BLK) PT Raised to $682.00 at Credit Suisse Group

    Advantage Investment Management LLC boosted its stake in BlackRock by 54.9% during the 4th quarter. (NYSE:BLK) for 27,740 shares. Wellington Shields And Com Ltd Liability Corporation stated it has 0.28% of its portfolio in CVS Health Corporation (NYSE:CVS).

    Unitedhealth Group Inc (NYSE:UNH) Shifting Institutional Investors Sentiment

    The stock, as of last close, traded 42.23% away to its 52 week low and was at a distance of -5.49% from its 52 week high. The healthcare conglomerate reported $3.04 EPS for the quarter, beating the Zacks' consensus estimate of $2.91 by $0.13.

    Incyte (INCY) Scheduled to Post Quarterly Earnings on Tuesday

    The biopharmaceutical company reported $0.02 EPS for the quarter, beating the Zacks' consensus estimate of ($0.52) by $0.54. Following the sale, the insider now directly owns 12,922 shares in the company, valued at approximately $1,105,606.32.
  • Anticipated $0.84 EPS for Tiffany & Co. (TIF) on May, 23

    Nine research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Piedmont Advsrs Limited Company invested in 0.56% or 207,665 shares. 9,572 were accumulated by Benjamin F Edwards And Com.
    'Holy' man jailed for life after raping teen

    'Holy' man jailed for life after raping teen

    In her complaint to police in 2013, the girl accused Bapu of raping her when she visited his retreat in Jodhpur with her mother. The case against him stems from 2013, when he was arrested on suspicion of sexually assaulting the girl, who was then 16.

    $0.89 EPS Expected for Berry Global Group, Inc

    The firm owned 17,376 shares of the industrial products company's stock after buying an additional 3,267 shares during the period. It worsened, as 39 investors sold MSFT shares while 1012 reduced holdings. 168 funds opened positions while 667 raised stakes.
  • How Analysts Rated The Blackstone Group LP (NYSE:BX) Last Week?

    In related news, insider Kathleen Skero sold 11,000 shares of the company's stock in a transaction dated Monday, August 15th. The stock of GTT Communications, Inc. 22,000 shares were sold by Finley John G, worth $751,300 on Friday, February 23.

    Laboratory Corp. of America (LH) Upgraded by ValuEngine to Buy

    Qs Investors Limited Liability Corp has invested 0.01% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Ameriprise stated it has 0% of its portfolio in OncoMed Pharmaceuticals, Inc. 60,475 are held by Connor Clark Lunn Mgmt Ltd.
    Marlins Beat Rockies 3-0 As Smith Records First Career Win

    Marlins Beat Rockies 3-0 As Smith Records First Career Win

    The Rockies, who led the National League in runs scored last season, managed to score just two runs in the series. Rojas said the unexpected pop stems from playing regularly. "But I just want to get on base".
  • Whole Foods Slammed Over 'Yellow Fever' Restaurant

    Whole Foods Slammed Over 'Yellow Fever' Restaurant

    After opening their first location in late 2013, the husband-wife duo gained enough traction to open an additional two locations. But the phrase is also a common reference to a term associated with a white man's sexual fascination with Asian women.

    The Ultimate Software Group (ULTI) Rating Lowered to Hold at BidaskClub

    On Friday, January 8 the stock rating was upgraded by Jefferies to "Buy". (NASDAQ:ULTI) on Monday, August 14 with "Buy" rating. Following the transaction, the director now owns 9,145 shares in the company, valued at approximately $2,090,821.35.

    Can analysts adopt a bullish outlook for Nuance Communications, Inc. (NASDAQ:NUAN)?

    As per Wednesday, October 14, the company rating was downgraded by JMP Securities. (NYSE:SERV) rating on Friday, September 15. The institutional investor owned 27,800 shares of the software maker's stock after selling 43,974 shares during the quarter.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.